It's a pleasure Burnett. Better news for you, I've got one from...

  1. 2,800 Posts.
    It's a pleasure Burnett. Better news for you, I've got one from Citi and one from UBS. Hope it helps.

    Citi rates BBG as Upgrade to Buy, High Risk from Neutral (1) -

    Target 33c (was 25c). The broker has sighed a breath of relief, noting insolvency has been avoided, at a cost. The Dakine brand will be sold and existing shareholders will be diluted from 100% to as low as 60% of the new register, says Citi. On the other hand, a dire risk is removed and the company will survive.

    The company has secured $458m in new debt facilities, although interest rates run as high as 12%. The broker now predicts a small loss in EPS for FY14 and a positive, if minor result in FY15. Citi also warns a turnaround will take patience. Billabong’s brands remain intact and with less debt pressure, Citi thinks profit margins could recover. Upgrade to Buy from Neutral, with a high risk tag of course.

    Target price is $0.33 Current Price is $0.25 Difference: $0.08

    If BBG meets the Citi target it will return approximately 32% (excluding dividends, fees and charges).

    The company's fiscal year ends in June. Citi forecasts a full year FY13 dividend of 0.00 cents and EPS of 2.00 cents.
    At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 12.50.

    Market Sentiment: -0.1

    -----

    UBS rates BBG as Neutral (3) -

    The broker notes the company has been able to put together a re-financing deal, although it is via a highly dilutive agreement with Altamont Capital. Interest costs are steep, DaKine will be sold off for $70m and existing shareholders will have holding diluted to between 59.51% and 63.75% of original holdings

    There is no change to FY13 guidance, although the broker reckons on preliminary numbers the deal will be around 54% dilutive to FY15 diluted EPS. The Neutral call and 25c price target are maintained, the broker waiting to hear what is said at the upcoming EGM.

    Target price is $0.25 Current Price is $0.25 Difference: $0
    If BBG meets the UBS target it will return approximately 0% (excluding dividends, fees and charges).

    The company's fiscal year ends in June. UBS forecasts a full year FY13 dividend of 0.00 cents and EPS of 2.00 cents.
    At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 12.50.

    Market Sentiment: -0.1

    :)
 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.